Mitigating Risk and Complexity in Cell & Gene Therapy Trials with IRT

Register Free: https://www.appliedclinicaltrialsonline.com/act_w/gene-therapy-trials
Event overview

Join us to discuss strategies for mitigating the complexities of cell and gene therapy (CGT) trials while reducing risk and cost. CGTs promise critical and transformative benefits to patients. Even with record funding and new launches in this sector, trial and patient journey complexities pose significant barriers to the success and sustainability of these treatments. CGT pioneers require supply chain partnerships that mitigate trial risk and complexity and provide a consultative approach to protocol execution. This webinar will explore how to succeed by optimizing pre-trial and pre-screening activities, as well as reducing trial cost and risk with your interactive response technology (IRT) solution.

Three key take-aways

Cara Woodruff
Director, Product Management, IQVIA IRT
IQVIA

Cara Woodruff is a highly motivated IT product management professional with over 29 years of experience in the biopharmaceutical service industry. She executes product strategy, defines product vision and roadmaps, develops customer-driven product requirements incorporating human-centered design, drives product release cycles using Agile methodologies, and collaborates with cross-functional teams to deliver high-quality solutions on time. Woodruff’s prior roles include IT product owner, IT business partner, integrated processes and technologies POC project/product manager, predictive analytics lead SAS developer, biostatistics senior SAS statistical programmer, statistical programming manager, clinical data programmer, and associate biostatistician.

Register Free: https://www.appliedclinicaltrialsonline.com/act_w/gene-therapy-trials